Cardiac Surgery 2019 Reviewed

Abstract

For the year 2019, almost 25,000 published references can be found in PubMed when entering the search term “cardiac surgery.” We used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses approach for article selection and reviewed the main fields of adult cardiac surgery (i.e., coronary, valve, aortic, and heart failure surgery). The past decade has experienced an enormous development of interventional techniques that compete more and more with classic surgery. This contest was broadly visible in 2019. It peaked over the interpretation of the EXCEL trial data, where percutaneous coronary intervention and coronary artery bypass grafting (CABG) for left main disease were compared. A novel pathomechanism for CABG was proposed, potentially answering open questions in the field. In aortic valve surgery, two low-risk trials comparing transcatheter aortic valve implantation (TAVI) to classic aortic valve replacement (surgical aortic valve replacement) received attention for showing equal or superior short-term outcomes for TAVI. Longer follow-up information from recent trials became available presenting results emphasizing the need for joint decision making. While publications addressing surgery on the aorta and the mitral and tricuspid valves were less abundant, there was substantial activity regarding left ventricular assist device support and heart transplantation. This article attempts to summarize the most pertinent publications. It does not expect to be complete and cannot be free of individual interpretation. We aimed to provide a condensed summary of 2019s publications with a stimulus for in-depth reading and a basis supporting patient information.

Keywords

coronary revascularization - aortic valve surgery - mitral valve surgery - tricuspid valve surgery - left ventricular assist device - heart transplantation

• References

• 1 Head SJ, Milojevic M, Daemen J. , et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet 2018; 391 (10124): 939-948
• 2 Neumann FJ, Sousa-Uva M, Ahlsson A. , et al; ESC Scientific Document Group. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2019; 40 (02) 87-165
• 3 Doenst T, Haverich A, Serruys P. , et al. PCI and CABG for treating stable coronary artery disease: JACC review topic of the week. J Am Coll Cardiol 2019; 73 (08) 964-976
• 4 Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92 (03) 657-671
• 5 Stergiopoulos K, Boden WE, Hartigan P. , et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 2014; 174 (02) 232-240
• 6 Jeon C, Candia SC, Wang JC. , et al. Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: a model for protection from acute myocardial infarction. Am Heart J 2010; 160 (01) 195-201
• 7 Lee PH, Park H, Lee JS, Lee SW, Lee CW. Meta-analysis comparing the risk of myocardial infarction following coronary artery bypass grafting versus percutaneous coronary intervention in patients with multivessel or left main coronary artery disease. Am J Cardiol 2019; 124 (06) 842-850
• 8 Farkouh ME, Domanski M, Dangas GD. , et al; FREEDOM Follow-On Study Investigators. Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study. J Am Coll Cardiol 2019; 73 (06) 629-638
• 9 Ebrahim MEBM, Dignan R, Femia G. , et al. Late clinical outcomes of unselected patients with diabetic mellitus and multi-vessel coronary artery disease. Int J Cardiol 2019; 296: 21-25
• 10 Sá MPBO, Perazzo AM, Saragiotto FAS. , et al. Coronary artery bypass graft surgery improves survival without increasing the risk of stroke in patients with ischemic heart failure in comparison to percutaneous coronary intervention: a meta-analysis with 54,173 patients. Braz J Cardiovasc Surg 2019; 34 (04) 396-405
• 11 Ram E, Sternik L, Klempfner R. , et al. Outcomes of different revascularization strategies among patients presenting with acute coronary syndromes without ST elevation. J Thorac Cardiovasc Surg 2019; •••: S0022-5223(19)32010-0
• 12 Freitas P, Madeira M, Raposo L. , et al. Coronary artery bypass grafting versus percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction and left main or multivessel coronary disease. Am J Cardiol 2019; 123 (05) 717-724
• 13 Thuijs DJFM, Kappetein AP, Serruys PW. , et al; SYNTAX Extended Survival Investigators. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet 2019; 394 (10206): 1325-1334
• 14 Gaipov A, Molnar MZ, Potukuchi PK. , et al. Predialysis coronary revascularization and postdialysis mortality. J Thorac Cardiovasc Surg 2019; 157 (03) 976-983.e7
• 15 Stone GW, Kappetein AP, Sabik JF. , et al; EXCEL Trial Investigators. Five-year outcomes after PCI or CABG for left main coronary disease. N Engl J Med 2019; 381 (19) 1820-1830
• 16 Ruel M, Falk V, Farkouh ME. , et al. Myocardial revascularization trials. Circulation 2018; 138 (25) 2943-2951
• 17 Holm NR, Makikallio T, Lindsay MM. , et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet 2020; 395 (10219): 191-199
• 18 Boden WE, O'Rourke RA, Teo KK. , et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356 (15) 1503-1516
• 19 Panza JA, Ellis AM, Al-Khalidi HR. , et al. Myocardial viability and long-term outcomes in ischemic cardiomyopathy. N Engl J Med 2019; 381 (08) 739-748
• 20 Garzillo CL, Hueb W, Gersh B. , et al. Association between stress testing-induced myocardial ischemia and clinical events in patients with multivessel coronary artery disease. JAMA Intern Med 2019; 179 (10) 1345-1351
• 21 Collet C, Onuma Y, Andreini D. , et al. Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease. Eur Heart J 2018; 39 (41) 3689-3698
• 22 Sonck J, Miyazaki Y, Collet C. , et al. Feasibility of planning coronary artery bypass grafting based only on coronary computed tomography angiography and CT-derived fractional flow reserve: a pilot survey of the surgeons involved in the randomized SYNTAX III Revolution trial. Interact Cardiovasc Thorac Surg 2019; •••: ivz046
• 23 Toth GG, De Bruyne B, Kala P. , et al. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial. EuroIntervention 2019; 15 (11) e999-e1005
• 24 Glineur D, Grau JB, Etienne PY. , et al. Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial. Eur Heart J 2019; 40 (29) 2421-2428
• 25 Benedetto U, Puskas J, Kappetein AP. , et al. Off-pump versus on-pump bypass surgery for left main coronary artery disease. J Am Coll Cardiol 2019; 74 (06) 729-740
• 26 Rufa MI, Ursulescu A, Nagib R. , et al. Off-pump versus on-pump redo coronary artery bypass grafting: a propensity score analysis of long-term follow-up. J Thorac Cardiovasc Surg 2019; •••: S0022-5223(19)30971-7
• 27 Diegeler A, Börgermann J, Kappert U. , et al. Five-year outcome after off-pump or on-pump coronary artery bypass grafting in elderly patients. Circulation 2019; 139 (16) 1865-1871
• 28 Chikwe J, Sun E, Hannan EL. , et al. Outcomes of second arterial conduits in patients undergoing multivessel coronary artery bypass graft surgery. J Am Coll Cardiol 2019; 74 (18) 2238-2248
• 29 Ruttmann E, Dietl M, Feuchtner GM. , et al; RADIAL Investigators. Long-term clinical outcome and graft patency of radial artery and saphenous vein grafts in multiple arterial revascularization. J Thorac Cardiovasc Surg 2019; 158 (02) 442-450
• 30 Samadashvili Z, Sundt III TM, Wechsler A. , et al. Multiple versus single arterial coronary bypass graft surgery for multivessel disease. J Am Coll Cardiol 2019; 74 (10) 1275-1285
• 31 Taggart DP, Benedetto U, Gerry S. , et al; Arterial Revascularization Trial Investigators. Bilateral versus single internal-thoracic-artery grafts at 10 years. N Engl J Med 2019; 380 (05) 437-446
• 32 Taggart DP. Randomized comparison of single versus bilateral internal thoracic artery grafts in 3102 CABG patients: major cardiovascular outcomes at ten years of follow up. Paper presented at the European Society of Cardiology; Munich, Germany; 2018
• 33 Schunkert H, Boening A, von Scheidt M. , et al. Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial. Eur Heart J 2019; 40 (29) 2432-2440
• 34 Bjorklund E, Nielsen SJ, Hansson EC. , et al. Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry. Eur Heart J 2020; 41 (17) 1653-1661
• 35 Popma JJ, Deeb GM, Yakubov SJ. , et al; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019; 380 (18) 1706-1715
• 36 Mack MJ, Leon MB, Thourani VH. , et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380 (18) 1695-1705
• 37 Siontis GCM, Overtchouk P, Cahill TJ. , et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J 2019; 40 (38) 3143-3153
• 38 Makkar RR, Thourani VH, Mack MJ. , et al; PARTNER 2 Investigators. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med 2020; 382 (09) 799-809
• 39 Barbanti M, Tamburino C, D'Errigo P. , et al; OBSERVANT Research Group. Five-year outcomes of transfemoral transcatheter aortic valve replacement or surgical aortic valve replacement in a real world population. Circ Cardiovasc Interv 2019; 12 (07) e007825
• 40 Schaefer A, Schofer N, Goßling A. , et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysis. Eur J Cardiothorac Surg 2019; 56 (06) 1131-1139
• 41 Capodanno D, Søndergaard L, Tamburino C. Durability of transcatheter bioprosthetic aortic valves: the story so far. EuroIntervention 2019; 15 (10) 846-849
• 42 Sondergaard L, Costa G. Transcatheter aortic valve replacement in patients with aortic stenosis and low surgical risk. J Am Coll Cardiol 2019; 74 (12) 1541-1542
• 43 Armoiry X, Obadia JF, Pascal L, Polazzi S, Duclos A. Comparison of transcatheter versus surgical aortic valve implantation in high-risk patients: a nationwide study in France. J Thorac Cardiovasc Surg 2018; 156 (03) 1017-1025.e4
• 44 Thourani VH. Five-year Outcomes from the PARTNER 2A Trial: Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients. Paper presented at the EACTS; Lisbon, Portugal; 2019
• 45 Asami M, Windecker S, Praz F. , et al. Transcatheter aortic valve replacement in patients with concomitant mitral stenosis. Eur Heart J 2019; 40 (17) 1342-1351
• 46 Makkar RR, Fontana G, Jilaihawi H. , et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 2015; 373 (21) 2015-2024
• 47 Kang DH, Park SJ, Lee SA. , et al. Early surgery or conservative care for asymptomatic aortic stenosis. N Engl J Med 2020; 382 (02) 111-119
• 48 Hernandez-Vaquero D, Diaz R, Alperi A. , et al. Life expectancy of patients undergoing surgical aortic valve replacement compared with that of the general population. Interact Cardiovasc Thorac Surg 2020; 30 (03) 394-399
• 49 Diaz R, Hernandez-Vaquero D, Alvarez-Cabo R. , et al. Long-term outcomes of mechanical versus biological aortic valve prosthesis: systematic review and meta-analysis. J Thorac Cardiovasc Surg 2019; 158 (03) 706-714.e18
• 50 Ikeno Y, Mukohara N, Fukumura Y. , et al. Outcomes of valve replacement with mechanical prosthesis versus bioprosthesis in dialysis patients: a 16-year multicenter experience. J Thorac Cardiovasc Surg 2019; 158 (01) 48-56.e4
• 51 Iribarne A, Leavitt BJ, Robich MP. , et al; Northern New England Cardiovascular Disease Study Group. Tissue versus mechanical aortic valve replacement in younger patients: a multicenter analysis. J Thorac Cardiovasc Surg 2019; 158 (06) 1529-1538.e2
• 52 Manghelli JL, Carter DI, Khiabani AJ. , et al. A 20-year multicenter analysis of dialysis-dependent patients who had aortic or mitral valve replacement: implications for valve selection. J Thorac Cardiovasc Surg 2019; 158 (03) 805-813.e2
• 53 Nakatsu T, Minakata K, Tanaka S, Minatoya K. ; PROGRESS-Kyoto Investigators. Intermediate-term outcomes of aortic valve replacement with bioprosthetic or mechanical valves in patients on hemodialysis. J Thorac Cardiovasc Surg 2019; 157 (06) 2177-2186.e3
• 54 Rodríguez-Caulo EA, Macías D, Adsuar A. , et al. Biological or mechanical prostheses for isolated aortic valve replacement in patients aged 50-65 years: the ANDALVALVE study. Eur J Cardiothorac Surg 2019; 55 (06) 1160-1167
• 55 Asch FM, Grayburn PA, Siegel RJ. , et al; COAPT Investigators. Echocardiographic outcomes after transcatheter leaflet approximation in patients with secondary mitral regurgitation: the COAPT trial. J Am Coll Cardiol 2019; 74 (24) 2969-2979
• 56 Iung B, Armoiry X, Vahanian A. , et al; MITRA-FR Investigators. Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years. Eur J Heart Fail 2019; 21 (12) 1619-1627
• 57 Doenst T, Bargenda S, Kirov H. , et al. Cardiac surgery 2018 reviewed. Clin Res Cardiol 2019; 108 (09) 974-989
• 58 Crestanello JA, Oh JK, Schaff HV. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2019; 380 (20) 1978
• 59 Stone GW, Lindenfeld J, Abraham WT. , et al; COAPT Investigators. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018; 379 (24) 2307-2318
• 60 Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging 2019; 12 (02) 353-362
• 61 Harmel E, Pausch J, Gross T. , et al. Standardized subannular repair improves outcomes in type IIIb functional mitral regurgitation. Ann Thorac Surg 2019; 108 (06) 1783-1792
• 62 Bothe W, Doenst T. Ring-Noose-String technique allows adjustable papillary muscle repositioning during minimally invasive mitral valve repair in patients with functional/ischemic mitral regurgitation. Thorac Cardiovasc Surg 2016; 64 (05) 447-449
• 63 Buzzatti N, Van Hemelrijck M, Denti P. , et al. Transcatheter or surgical repair for degenerative mitral regurgitation in elderly patients: a propensity-weighted analysis. J Thorac Cardiovasc Surg 2019; 158 (01) 86-94.e1
• 64 Jung JC, Jang MJ, Hwang HY. Meta-analysis comparing mitral alve repair versus replacement for degenerative mitral regurgitation across all ages. Am J Cardiol 2019; 123 (03) 446-453
• 65 Ma W, Tan Y, Shi Q, Xu Z. Continuous beta-blocker therapy delays structural deterioration after bioprosthetic mitral valve replacement. Thorac Cardiovasc Surg 2019; 67 (07) 554-556
• 66 Patel NC, Hemli JM, Seetharam K. , et al. Reoperative mitral valve surgery via sternotomy or right thoracotomy: a propensity-matched analysis. J Card Surg 2019; 34 (10) 976-982
• 67 Saran N, Dearani JA, Said SM. , et al. Long-term outcomes of patients undergoing tricuspid valve surgery. Eur J Cardiothorac Surg 2019; 56 (05) 950-958
• 68 Pingpoh C, Nuss S, Kueri S. , et al. Adding tricuspid repair to standard open heart surgery does not increase risk but improves right ventricular function. Interact Cardiovasc Thorac Surg 2019; 29 (03) 416-421
• 69 Hamandi M, Smith RL, Ryan WH. , et al. Outcomes of isolated tricuspid valve surgery have improved in the modern era. Ann Thorac Surg 2019; 108 (01) 11-15
• 70 Axtell AL, Bhambhani V, Moonsamy P. , et al. Surgery does not improve survival in patients with isolated severe tricuspid regurgitation. J Am Coll Cardiol 2019; 74 (06) 715-725
• 71 Abe T, Yamamoto H, Miyata H. , et al. Patient trends and outcomes of surgery for type A acute aortic dissection in Japan: an analysis of more than 10 000 patients from the Japan Cardiovascular Surgery Database. Eur J Cardiothorac Surg 2020; 57 (04) 660-667
• 72 Chiu P, Rotto TJ, Goldstone AB, Whisenant JB, Woo YJ, Fischbein MP. Time-to-operation does not predict outcome in acute type A aortic dissection complicated by neurologic injury at presentation. J Thorac Cardiovasc Surg 2019; 158 (03) 665-672
• 73 Yang B, Norton EL, Rosati CM. , et al. Managing patients with acute type A aortic dissection and mesenteric malperfusion syndrome: a 20-year experience. J Thorac Cardiovasc Surg 2019; 158 (03) 675-687.e4
• 74 Mehra MR, Uriel N, Naka Y. , et al; MOMENTUM 3 Investigators. A fully magnetically levitated left ventricular assist device - final report. N Engl J Med 2019; 380 (17) 1618-1627
• 75 Converse MP, Sobhanian M, Taber DJ, Houston BA, Meadows HB, Uber WE. Effect of angiotensin II inhibitors on gastrointestinal bleeding in patients with left ventricular assist devices. J Am Coll Cardiol 2019; 73 (14) 1769-1778
• 76 Potapov EV, Antonides C, Crespo-Leiro MG. , et al. 2019 EACTS Expert Consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg 2019; 56 (02) 230-270
• 77 Yau TM, Pagani FD, Mancini DM. , et al; Cardiothoracic Surgical Trials Network. Intramyocardial injection of mesenchymal precursor cells and successful temporary weaning from left ventricular assist device support in patients with advanced heart failure: a randomized clinical trial. JAMA 2019; 321 (12) 1176-1186
• 78 Truby LK, Farr MA, Garan AR. , et al. Impact of bridge to transplantation with continuous-flow left ventricular assist devices on posttransplantation mortality. Circulation 2019; 140 (06) 459-469
• 79 Axtell AL, Fiedler AG, Lewis G. , et al. Reoperative sternotomy is associated with increased early mortality after cardiac transplantation. Eur J Cardiothorac Surg 2019; 55 (06) 1136-1143
• 80 Woolley AE, Singh SK, Goldberg HJ. , et al; DONATE HCV Trial Team. Heart and lung transplants from HCV-infected donors to uninfected recipients. N Engl J Med 2019; 380 (17) 1606-1617
• 81 Chew HC, Iyer A, Connellan M. , et al. Outcomes of donation after circulatory death heart transplantation in Australia. J Am Coll Cardiol 2019; 73 (12) 1447-1459
• 82 Messer S, Page A, Axell R. , et al. Outcome after heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant 2017; 36 (12) 1311-1318